Hims & Hers Health, Inc.
شراء

HIMS Long — $HIMS breaking out above $31 resistance on volume —

285
HTF (4h): HIMS carved a clear V-shaped recovery from the ~$22 May lows, making HH/HL structure all the way back to the prior April highs near $30–31. The most recent 4h candles are pressing into and through the $30–31 resistance shelf that capped the April 23 swing high (~$28–30 zone). Price is now printing a fresh HH above that resistance, confirming a structural BOS to the upside. The $29–30 zone has been tested and held multiple times, validating it as a breakout reference. LTF (1h): The June 15–16 sequence is a clean accelerating breakout — gap up June 15, consolidation above $29.50, then today's gap open above $30 with a strong green candle to $31.95 high and current bid $31.62. The last 1h bar (09:30 ET) opened $31.53, high $31.79, close $31.62 — holding well above prior resistance. Stop is placed below the breakout retest zone / June 15 open gap at $30.55 (below the June 16 open low of $29.68 plus buffer ~0.4× ATR = $29.68 + 0.41 = ~$30.10 is too tight; using the June 15 consolidation low of $29.43 + 0.5 ATR = $29.93… however, the more conservative invalidation is back inside the $30 range — using $30.55 as the level where the breakout is negated, ~1.07 from entry, which is just above 1× ATR). Target is the next structural supply at the April highs near $33.80 (prior April 23 peak area ~$28, but the January 2026 prior swing zone was ~$33–34, confirmed by JPMorgan PT $33). R/R = (33.80−31.62)/(31.62−30.55) = 2.18/1.07 = 2.04 — passes gate. Research: Q1 miss and EBITDA compression are known/priced post-May 12 selloff; the Novo Nordisk/Wegovy partnership is a credible strategic pivot; insider buy at $24.23 in late May is a T1 positive signal; new CMO appointment bullish near-term; JPMorgan Overweight $33 PT aligns with target. BofA/Truist lower PTs are a mild cap. Earnings Aug 3 is 48 days out, well outside a swing horizon. No binary event veto. Regime neutral, no adjustment. Base 65; scan hint +5 (Breakout/LONG aligned); research net +3 (insider buy + JPM PT aligned, partially offset by BofA/Truist bears); regime 0 → 73. Clamped: 68 (discount for extended entry, 2.3× ATR extension flagged by scan).

📍 Entry: 31.62
🛑 Stop: 30.55
🎯 Target: 33.80
⚖️ R:R: 2.04

إخلاء المسؤولية

لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.